Vimarsana
Biggest News Aggregation in the World

Paulf Lizzul News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Paulf Lizzul. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Paulf Lizzul Today - Breaking & Trending Today

AnaptysBio, Inc. (NASDAQ:ANAB) Receives $39.20 Consensus Price Target from Analysts - Vimarsana News

AnaptysBio, Inc. (NASDAQ:ANAB) Receives $39.20 Consensus Price Target from Analysts

Shares of AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) have been given an average recommendation of “Hold” by the five analysts that are currently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month price […]

Insider Selling: AnaptysBio, Inc. (NASDAQ:ANAB) Insider Sells 2,554 Shares of Stock - Vimarsana News

Insider Selling: AnaptysBio, Inc. (NASDAQ:ANAB) Insider Sells 2,554 Shares of Stock

AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) insider Paul F. Lizzul sold 2,554 shares of the firm’s stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $21.81, for a total transaction of $55,702.74. Following the completion of the sale, the insider now owns 10,118 shares of the […]

Insider Selling: AnaptysBio, Inc. (NASDAQ:ANAB) Insider Sells $55,702.74 in Stock - Vimarsana News

Insider Selling: AnaptysBio, Inc. (NASDAQ:ANAB) Insider Sells $55,702.74 in Stock

AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) insider Paul F. Lizzul sold 2,554 shares of the business’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $21.81, for a total value of $55,702.74. Following the completion of the sale, the insider now directly owns 10,118 shares of […]

Source: wkrb13.com
AnaptysBio, Inc. (NASDAQ:ANAB) Receives $29.00 Average Price Target from Brokerages - Vimarsana News

AnaptysBio, Inc. (NASDAQ:ANAB) Receives $29.00 Average Price Target from Brokerages

AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) has been given a consensus rating of “Hold” by the five brokerages that are currently covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 12 month price objective […]

AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Rating of "Hold" by Analysts - Vimarsana News

AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Rating of "Hold" by Analysts

Shares of AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) have been given a consensus recommendation of “Hold” by the five analysts that are covering the firm, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price objective among […]

Source: wkrb13.com